Loading clinical trials...
Loading clinical trials...
Contribution of Homocysteine and Asymmetric Dimethylarginine to Atherosclerosis and Cardiovascular Events in Maintenance Hemodialysis Patients
Conditions
Locations
1
Japan
University of Shizuoka
Shizuoka, Shizuoka, Japan
Start Date
April 1, 2000
Completion Date
March 1, 2005
Last Updated
October 21, 2005
NCT07241390
NCT01143454
NCT05316311
NCT07462741
NCT02932176
NCT06535568
Lead Sponsor
University of Shizuoka
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions